The global dental bone grafts and substitutes market is poised to register significant growth over the forecast period. Increasing use of bone grafts in dentistry, clubbed with number of dental implant surgeries are key growth drivers to this market. Furthermore, rising usage of biocompatible and synthetic dental grafts is another growth propelling factor for the market. TCp is mostly used as a synthetic scaffold in dentistry. It provides higher osteoconductivity as compared to allografts.
Based on product the dental bone grafts substitutes market is segmented into allograft, xenograft and synthetic. Xenograft held the largest revenue share as of 2018. Xenograft is the bone taken from an animal source such as bovine and implanted into human’s body. The most commonly used xenograft is Bio-Oss. Key industry players are introducing new xenograft products for better penetration. For instance, in 2019 Marks Biotech Inc. launched Novobone, a xenograft in order to improve its bone grafting product portfolio. The other key players include ACE Surgical, BioHorizons etc.
Socket preservation held the largest revenue share of the dental bone grafts market application segment as of 2018. It is a method used to decrease bone loss after tooth extraction from tooth socket in the alveolar bone. An escalating number of dental implant surgeries and increasing awareness among people about oral health care are the driving factors for the growth of this segment. Ridge augmentation owing to its quick recovery time and painless procedure, is anticipated to register significant growth over the forecast period. The demand is aligned in response to achieve long term survival and successful implant placement.
Increasing collaborative agreements between hospitals and tissue banks aiming to provide end to end services is increasing patients footfall in the hospital facilities. Moreover, better insurance coverage and wide array of surgical procedures are responsible for the dominant share of hospitals in the end use market in 2018.
Europe dominated the global dental bone grafts substitutes market in terms of revenue share in 2018. Increasing target population and number of dental implant surgeries in this region are driving the growth. North America held the second largest share and is expected to show steady growth in the coming years.
The industry is marked by the presence of various small and large industry players. The dental bone grafts market is competitive and highly fragmented especially at the country level in Asia Pacific region. Key global industry players include Geistlich Pharma AG, Medtronic, Zimmer Holding Inc, RTI Surgical, Inc., Dentsply Sirona etc. Geistlich, ACE Surgical, Zimmer Biomet & BioHorizons held the major share of the U.S. as of 2018.
In-depth report on global dental bone grafts & substitutes market by Grand View Research: